Malignant tumours of the kidney: imaging strategy

Malignant Tumours of the Kidney

was first established by Robin in 1855. Later, yellow coloured tumours of small or large size, well circumscribed, vascular, liable to haemorrhages, degeneration and cyst formation were noticed in the region of the kidney, which led pathologists to speculate concerning their origin. At first they were thought to be lipomatous in structure until Grawitz in 1883 thought that the structure was ide...

Antisense strategy in malignant brain tumours treatment.

Malignant glioma, the most common human brain cancer, is almost uniformly fatal. Median survival is less than one year. The principal strategies of gene therapy for treatment of gliomas, including antisense approach, have been proposed comming from 1990s [1, 2, 3, 4]. The antisense oligonucleotides become the important tool of anti-cancer approach [5, 6]. The "discovery" of antisense approach w...

Affibody-mediated PET imaging of HER3 expression in malignant tumours

Human epidermal growth factor receptor 3 (HER3) is involved in the progression of various cancers and in resistance to therapies targeting the HER family. In vivo imaging of HER3 expression would enable patient stratification for anti-HER3 immunotherapy. Key challenges with HER3-targeting are the relatively low expression in HER3-positive tumours and HER3 expression in normal tissues. The use o...

The Origin of Malignant Tumours

t0 t,pr?duced by adding a very large quantity of sperm the 'C a,1(^ violently shaking or pressing the ova; otilyreSUiting 'nrv;c wcrc "early all pathological, and a few normals were found. The triastcr type of division was produced by shaking the eggs immediately after fertilisation; these gave rise to a large number of normal as well as pathological embryos. The double spindle type occurred mo...

Malignant Tumours of the Kidneys.